コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 d rhodamines as PET radiopharmaceuticals for myocardial perfusion imaging.
2 ositron emission tomography (PET) tracer for myocardial perfusion imaging.
3 lantation, strain-rate echocardiography, and myocardial perfusion imaging.
4 e of stress cardiac magnetic resonance (CMR) myocardial perfusion imaging.
5 in patients with and without ischemia on PET myocardial perfusion imaging.
6 in patients with and without ischemia on PET myocardial perfusion imaging.
7 medications may modify the results of stress myocardial perfusion imaging.
8 arkers and single photon emission CT (SPECT) myocardial perfusion imaging.
9 h before adenosine stress on the results of myocardial perfusion imaging.
10 it from risk stratification with vasodilator myocardial perfusion imaging.
11 armaceutical may also translate favorably to myocardial perfusion imaging.
12 consecutive patients undergoing gated SPECT myocardial perfusion imaging.
13 s the effectiveness of vasodilator stress in myocardial perfusion imaging.
14 tic patients may benefit from screening with myocardial perfusion imaging.
15 ion in increasing the diagnostic accuracy of myocardial perfusion imaging.
16 importance of electrocardiographic gating in myocardial perfusion imaging.
17 uke treadmill scores (> or =5) who underwent myocardial perfusion imaging.
18 tive to pharmacologic stress or exercise for myocardial perfusion imaging.
19 arly become an integral part of radionuclide myocardial perfusion imaging.
20 photon emission computed tomography (SPECT) myocardial perfusion imaging.
21 was equivalent to that obtained for clinical myocardial perfusion imaging.
22 assess their usefulness as vasodilators for myocardial perfusion imaging.
23 mole are alternatives to exercise stress for myocardial perfusion imaging.
24 en) without established CAD underwent stress myocardial perfusion imaging.
25 mation besides that provided by clinical and myocardial perfusion imaging.
26 ellent potential for use as vasodilators for myocardial perfusion imaging.
27 ing it a promising agent for pharmacological myocardial perfusion imaging.
28 may result in reduced diagnostic accuracy of myocardial perfusion imaging.
29 on, enhancing the clinical utility of stress myocardial perfusion imaging.
30 c value in patients with normal and abnormal myocardial perfusion imaging.
31 luded in patient risk estimation after SPECT myocardial perfusion imaging.
32 FR may improve the diagnostic performance of myocardial perfusion imaging.
33 C) scans are commonly obtained with SPECT/CT myocardial perfusion imaging.
34 iography, stress echocardiography, or stress myocardial perfusion imaging.
35 on rest/stress positron emission tomography myocardial perfusion imaging.
36 1 (Tl-201) as an alternative radiotracer for myocardial perfusion imaging.
37 ry angiography and single-photon emission CT myocardial perfusion imaging.
40 cian offices; this proportion was higher for myocardial perfusion imaging (74.8%) and cardiac compute
44 ween October 2004 and September 2011 who had myocardial perfusion imaging after negative troponin T t
45 echnetium (V) ((99m)Tc) ((99m)TcN-NOET) is a myocardial perfusion imaging agent demonstrating signifi
47 In recent years, several of 99mTc-labeled myocardial perfusion imaging agents have been developed,
48 e single-photon emission computed tomography myocardial perfusion imaging and angiography (invasive o
49 own CAD underwent prospectively simultaneous myocardial perfusion imaging and CAC scoring on a hybrid
52 ent rubidium-82 positron emission tomography myocardial perfusion imaging and did not have subsequent
53 w technologies and new applications, such as myocardial perfusion imaging and dual-energy CT, are bei
54 2051 patients who underwent exercise stress myocardial perfusion imaging and echo (5.5+/-7.9 days),
55 s used with both 99mTc sestamibi (sestamibi) myocardial perfusion imaging and echocardiography for de
56 l issues in image interpretation specific to myocardial perfusion imaging and implications of use of
57 baseline suboptimal images and/or underwent myocardial perfusion imaging and received contrast agent
58 lights an expansive evidence base for stress myocardial perfusion imaging and reveals a decided advan
59 e patients with increased RV uptake on SPECT myocardial perfusion imaging and right heart catheteriza
60 rmation exists on the usefulness of combined myocardial perfusion imaging and RNA to predict prognosi
63 mic dilation (TID) after stress thallium-201 myocardial perfusion imaging and to provide further insi
64 ars to be a promising agent for clinical PET myocardial perfusion imaging and to warrant further clin
66 atio [H/M] on 4-h delayed planar images) and myocardial perfusion imaging and were then followed up f
67 -photon emission computed tomography (SPECT) myocardial perfusion imaging, and magnetic resonance ima
71 nnel blockers, beta-blockers, and statins on myocardial perfusion imaging are likely attributable to
72 se myocardial fibrosis imaging, and absolute myocardial perfusion imaging, are poised to further adva
73 e single photon emission computed tomography myocardial perfusion imaging as a tool for risk stratifi
74 r assessment of cardiac function, first-pass myocardial perfusion imaging at rest and during adenosin
75 consecutive CRT recipients with radionuclide myocardial perfusion imaging before CRT between January
76 CACS and (82)Rb positron emission tomography myocardial perfusion imaging between 2010 and 2016, were
77 were Veteran patients who underwent nuclear myocardial perfusion imaging between December 2010 and J
78 +/- 11.8 years), patients were referred for myocardial perfusion imaging between May 2008 and Januar
79 isoprolol, or metoprolol underwent adenosine myocardial perfusion imaging both on and off beta-blocka
81 otal of 409 patients with CAD, who underwent myocardial perfusion imaging by dipyridamole positron em
83 computed tomographic angiography and stress myocardial perfusion imaging by single photon emission c
84 was to determine the diagnostic accuracy of myocardial perfusion imaging by single-photon emission c
87 trocardiography, stress echocardiography, or myocardial perfusion imaging can reveal findings associa
88 hy (chi-square 9.21) and stress thallium-201 myocardial perfusion imaging (chi-square 16.76) were pre
89 fusion (CTP) with cardiac magnetic resonance myocardial perfusion imaging (CMR-Perf) for detection of
92 udy sought to assess the diagnostic value of myocardial perfusion imaging during exercise and pharmac
93 eadmill, radionuclide angiocardiography, and myocardial perfusion imaging--during a single exercise s
94 uation with pharmacologic stress testing and myocardial perfusion imaging, ejection fraction should b
95 ctional flow reserve (CT-FFR) and dynamic CT myocardial perfusion imaging enhance the specificity of
99 function and chamber morphology, as well as myocardial perfusion imaging for additional detection of
100 clinical positron emission tomography (PET) myocardial perfusion imaging for chest pain and/or dyspn
101 erate to severe AS underwent ammonia N13 PET myocardial perfusion imaging for myocardial blood flow (
102 h can therefore be used interchangeably with myocardial perfusion imaging for the detection of CAD.
103 duce the diagnostic sensitivity of adenosine myocardial perfusion imaging for the detection of flow-l
104 perfusion abnormalities detected using gated myocardial perfusion imaging (GMPI) in patients with eso
105 tection of stenosis > or =50%, whereas SPECT myocardial perfusion imaging had a sensitivity of 67% an
107 was first added to the clinical information, myocardial perfusion imaging had no incremental prognost
111 h-spatial-resolution cardiovascular MR (CMR) myocardial perfusion imaging has been shown to be clinic
113 e single photon emission computed tomography myocardial perfusion imaging has been validated in multi
114 nual cardiac mortality (>1%) is not low, and myocardial perfusion imaging has independent prognostic
117 single-photon emission computed tomographic myocardial perfusion imaging improved from a summed stre
119 photon emission computed tomographic (SPECT) myocardial perfusion imaging in men and women and the ef
121 ction compared with clinical information and myocardial perfusion imaging in patients undergoing phar
122 photon emission computed tomographic (SPECT) myocardial perfusion imaging in patients with chest pain
123 y, and prognostic value of dobutamine stress myocardial perfusion imaging in patients with known or s
124 high-resolution and standard-resolution CMR myocardial perfusion imaging in patients with suspected
127 t Association that assigns a larger role for myocardial perfusion imaging in the diagnosis of coronar
136 as obtained by positron emission tomography myocardial perfusion imaging is associated with all-caus
137 e single photon emission computed tomography myocardial perfusion imaging is capable of identifying l
138 dehyde-bis(n4-methylthiosemicarbazone (PTSM) myocardial perfusion imaging is compared with 99mTc-sest
140 One-day dipyridamole/rest 99mTc-tetrofosmin myocardial perfusion imaging is feasible and has a high
145 The diagnostic accuracy of thallium SPECT myocardial perfusion imaging is lower in women than in m
146 Duke treadmill scores and low clinical risk, myocardial perfusion imaging is of limited prognostic va
149 is of myocardial dynamic computed tomography myocardial perfusion imaging lacks standardization.
150 will aid in understanding the value of SPECT myocardial perfusion imaging, leverage hybrid imaging, a
151 (MBF) on positron emission tomography (PET) myocardial perfusion imaging may identify adverse myocar
152 atic analysis of dynamic computed tomography myocardial perfusion imaging may permit robust discrimin
155 of dobutamine stress (99m)Tc-sestamibi SPECT myocardial perfusion imaging might be impaired, owing to
156 racy of the 3 most commonly used noninvasive myocardial perfusion imaging modalities, single-photon e
158 eys the extensive literature on preoperative myocardial perfusion imaging (MPI) and outlines key tren
159 value of positron emission tomography (PET) myocardial perfusion imaging (MPI) and the improved clas
160 uate the prognostic value of community-based myocardial perfusion imaging (MPI) and to assess the inc
162 ve patients undergoing adenosine stress-rest myocardial perfusion imaging (MPI) by (99m)Tc-tetrofosmi
163 myocardial oxygen demand, vasodilator stress myocardial perfusion imaging (MPI) can be applied very e
164 photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI) during the first six
165 ate use criteria recommend performing stress myocardial perfusion imaging (MPI) for intermediate- to
166 ry artery disease who were undergoing stress myocardial perfusion imaging (MPI) from 5 centers were p
167 -photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI) has changed over time
168 -photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI) have shown a survival
169 -photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI) in a single academic
170 aluation for appropriate use of radionuclide myocardial perfusion imaging (MPI) in multiple clinical
171 lent prognosis, the significance of abnormal myocardial perfusion imaging (MPI) in patients with high
172 iogram (ECG) in relationship to stress-gated myocardial perfusion imaging (MPI) in postmenopausal wom
173 y (CCTA) to a strategy employing rest-stress myocardial perfusion imaging (MPI) in the evaluation of
174 Cardiovascular magnetic resonance (CMR) myocardial perfusion imaging (MPI) is a state-of-the-art
175 -photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI) is an effective metho
176 Caffeine consumption before adenosine stress myocardial perfusion imaging (MPI) is known to affect th
180 to determine the safety of dobutamine stress myocardial perfusion imaging (MPI) obtained by real-time
182 screened with adenosine-stress radionuclide myocardial perfusion imaging (MPI) or not to be screened
185 consecutive patients underwent (82)Rubidium myocardial perfusion imaging (MPI) positron emission tom
187 segmentation of the left ventricle for SPECT myocardial perfusion imaging (MPI) quantification often
188 tomography or (B) silent ischemia by stress myocardial perfusion imaging (MPI) remain controversial.
189 y was designed to determine how long nuclear myocardial perfusion imaging (MPI) remains abnormal foll
190 s in cancer patients who had abnormal stress myocardial perfusion imaging (MPI) results versus cancer
191 lity of a new protocol, IQ SPECT, to acquire myocardial perfusion imaging (MPI) studies in a quarter
192 mine the prognostic value of normal exercise myocardial perfusion imaging (MPI) tests and exercise ec
193 n emission computed tomography (gated SPECT) myocardial perfusion imaging (MPI) to detect defects in
194 It remains unclear whether the addition of myocardial perfusion imaging (MPI) to the standard ECG e
195 photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI) underwent a comprehen
196 simultaneous (201)Tl (stress)/(99m)Tc (rest) myocardial perfusion imaging (MPI) using a protocol that
199 easibility of attenuation correction (AC) of myocardial perfusion imaging (MPI) with a virtual unenha
201 artery calcium score (CACS) as an adjunct to myocardial perfusion imaging (MPI) with SPECT for cardia
203 impact of appropriate use criteria (AUC) for myocardial perfusion imaging (MPI) with SPECT on the est
204 mance for positron emission tomography (PET) myocardial perfusion imaging (MPI) with Tc-99m single-ph
206 -photon emission computed tomography (SPECT)-myocardial perfusion imaging (MPI), a technique that is
207 sensitivity has facilitated fast or low-dose myocardial perfusion imaging (MPI), and early dynamic im
208 tunity to lower the injected doses for SPECT myocardial perfusion imaging (MPI), but the exact limits
209 cent advances in CT coronary angiography and myocardial perfusion imaging (MPI), including PET MPI, i
219 In this study, we describe a protocol for myocardial perfusion imaging of mice using technetium-99
220 h BMI >/= 40 kg/m(2) should be scheduled for myocardial perfusion imaging on a conventional SPECT cam
222 ial blood flow as assessed by stress-induced myocardial perfusion imaging or a significant fall in di
223 mage quality of torso PET and compare stress myocardial perfusion imaging patterns with myocardial (1
224 CT imaging accounts for well over 90% of all myocardial perfusion imaging performed in the United Sta
226 : $2,878 to $4,579), as compared with stress myocardial perfusion imaging plus selective catheterizat
228 ought to determine whether changes in stress myocardial perfusion imaging protocols and camera techno
232 performed six or more months following PCI, myocardial perfusion imaging reliably identifies patient
233 erity improved prediction of an abnormal PET myocardial perfusion imaging result versus CCTA stenosis
234 significantly higher in patients with normal myocardial perfusion imaging results (6.5% +/- 5.4%) tha
235 econdary outcome was a comparison of nuclear myocardial perfusion imaging results and frequency of is
236 or of reduction in stroke volumes from gated myocardial perfusion imaging scans (range = 33-85 mL; p
238 s performed to fit stroke volumes from gated myocardial perfusion imaging scans with linear and quadr
239 ect differences in stroke volumes from gated myocardial perfusion imaging scans, we assessed its perf
241 amera system for high-speed SPECT (HS-SPECT) myocardial perfusion imaging shows excellent correlation
243 ocardial ischemia, LV mapping, compared with myocardial perfusion imaging, shows (1) mild reduction o
245 h single-photon emission computed tomography myocardial perfusion imaging (SPECT MPI) has improved th
246 t single-photon emission computed tomography-myocardial perfusion imaging (SPECT-MPI) has high predic
247 -photon emission computed tomography (SPECT) myocardial perfusion imaging studies among patients with
248 ce radiation exposure to patients undergoing myocardial perfusion imaging studies, especially when co
252 ests a reference range of TID for (82)Rb PET myocardial perfusion imaging that is in the range of pre
254 Likewise, in patients with ischemia on PET myocardial perfusion imaging, the annualized event rate
255 dy evaluated the ability of dipyridamole PET myocardial perfusion imaging to detect coronary collater
256 were followed for 6 months after their index myocardial perfusion imaging to determine subsequent rat
257 Gated SPECT has expanded the applications of myocardial perfusion imaging to include the evaluation o
259 T) examination incorporating stress and rest myocardial perfusion imaging together with coronary comp
261 d biodistribution of a potential cardiac PET myocardial perfusion imaging tracer, [(18)F]SYN2 ((18)F-
263 ombined Noninvasive Coronary Angiography and Myocardial Perfusion Imaging Using 320-Detector Row Comp
265 act of increased body mass on the quality of myocardial perfusion imaging using a latest-generation g
267 c part of positron emission tomography (PET) myocardial perfusion imaging using PET/CT, but anatomic
268 supplemented with results from acute resting myocardial perfusion imaging using single-photon emissio
269 n spent nuclear fuel cycle as well as toward myocardial perfusion imaging utilizing (82)Sr/(82)Rb iso
274 or abnormality for rest-stress (82)Rb PET/CT myocardial perfusion imaging were developed and validate
276 ardiography, stress echocardiography, and/or myocardial perfusion imaging were performed to identify
279 SPECT is most commonly used for clinical myocardial perfusion imaging, whereas PET is the clinica
280 nd software for positron emission tomography myocardial perfusion imaging, which has advanced it from
281 d 323 patients undergoing thallium-201 SPECT myocardial perfusion imaging who either had < 5% probabi
284 adenosine-stress dynamic computed tomography myocardial perfusion imaging with a second-generation du
290 tery disease (CAD) is ambiguous, but nuclear myocardial perfusion imaging with single-photon emission
291 onary artery calcium (CAC) scoring on top of myocardial perfusion imaging with single-photon emission
292 le myocardial ischemia was adjudicated using myocardial perfusion imaging with single-photon emission
294 ographic (single photon emission tomography) myocardial perfusion imaging with thallium-201 (n=173) o
295 This prospective randomized study assessed myocardial perfusion imaging with the high-sensitivity D
296 dings could lead to effective strategies for myocardial perfusion imaging with venous injections of m
297 e RT3DE technology offers an opportunity for myocardial perfusion imaging without multi-slice reconst
299 sk of adverse events and, therefore, in whom myocardial perfusion imaging would be valuable for risk